Abbott Labs (ABT) PT Lowered to $65 at Citi
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $116.64 +2.19%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 20
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 20
Join SI Premium – FREE
Citi lowered its price target on Abbott Labs (NYSE: ABT) to $65.00 (from $66.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Downgrades Unite Group (UTG:LN) to Underweight
- Guzman y Gomez Ltd (GYG:AU) PT Raised to AUD29 at UBS
- Ridley Corporation Limited (RIC:AU) PT Raised to AUD3.25 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
